GrowLab Pharmaceuticals

GrowLab Pharmaceuticals is a private African biopharmaceutical and medical-cannabis company focused on developing, manufacturing, and distributing cGMP-compliant phytocannabinoid-derived therapeutic formulations from proprietary cannabis genetics. The company markets products including Comacadine, Grolatine, and Klaro/Klaro Plus, and states that it has developed multiple proprietary strains for a range of disease areas. GrowLab also operates through a licensed Lesotho subsidiary for medicinal-cannabis cultivation, manufacturing, import/export, and supply, and has promoted plans for an EMA cGMP-compliant biopharmaceutical campus in Lesotho. In addition to product commercialization, the company offers wholesale supply, testing products, and professional education via its Medical Cannabis Research Institute. Publicly available evidence for its clinical pipeline is limited and consists largely of company-issued materials and press releases.